Literature DB >> 21147636

Respiratory infection caused by Chlamydophila pneumoniae in children and adolescents in the Lower Silesia Region of Poland.

Irena Choroszy-Krol1, I M Frej-Madrzak, D Teryks-Wolyniec, A Jama-Kmiecik, G Gosciniak, I Pirogowicz, M Pokorski.   

Abstract

OBJECTIVE: To assess the incidence of Chlamydia pneumoniae respiratory tract infection in children and adolescents in the Lower Silesia Region in Poland in 2009.
MATERIAL AND METHODS: 641 throat swabs obtained from 326 girls and 315 boys, aged 11 months to 18 years, were assessed diagnostically. The patients enrolled into the study were treated on an outpatient basis due to various, non-specific respiratory ailments. The most common presenting clinical symptom of a respiratory problem was dry cough, which occurred in 295 studied subjects, followed by runny nose and cough with discharge in 176 subjects, and other minor symptoms in 35 subjects. The assessment was conducted by an indirect immunofluorescence antibody (IFA) Chlamydia Testing kit (Cellabs, Sydney, Australia).
RESULTS: Overall, Chlamydia infection was detected in the respiratory tract in 43.1% (276/ 641) of the children, with no clear gender differences. Of the 295 subjects presenting with dry cough, 122 (41.4%) had positive tests for Chlamydia. Of the 176 subjects with runny nose and cough and the 35 subjects with other symptoms, 83 (47.2%) and 8 (22.9%) had positive tests for Chlamydia, respectively. In the asymptomatic children who had direct contact with a Chlamydia infected person, there were 29.6% (8/27) positively tested cases, whereas in the children presenting symptoms, the percentage of positive tests was 48.3% (29/60).
CONCLUSIONS: In children living in the Lower Silesia Region of Poland, there is a substantial ∼50% rate of Chlamydia infection, transmitted via airborne droplets. The finding of Chlamydia infection should be the signal for testing other subjects from the child's closest environment.

Entities:  

Mesh:

Year:  2010        PMID: 21147636      PMCID: PMC4360266          DOI: 10.1186/2047-783x-15-s2-112

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


Introduction

Chlamydophila pneumoniae is a common etiological factor of the respiratory tract infections, including pharyngitis, bronchitis, and pneumonia [1]. It is estimated that C. pneumoniae is responsible for pneumonia in approximately 10% of cases, and for bronchitis and sinusitis in approximately 5% of cases [2,3]. The main symptoms of infection include cough, pharyngitis and, hoarseness, often accompanied by sinusitis [4]. The course of infection may be biphasic. Pharyngitis occurs in the first phase, followed by bronchitis or pneumonia in the second phase of a disease. Prolonging cough (for more than 3 weeks) is a basic symptom indicating C. pneumoniae infection [4-6]. Respiratory tract infections of C. pneumoniae etiology are characterized by a long incubation period, usually lasting 14-21 days. The course of disease is age-dependent. The clinical symptoms of infection in children are mild compared with elderly people. Untreated infections can lead to many complications, such as exacerbations of bronchial asthma, endocarditis, coronary heart disease, endothelitis, and abortions [7-9]. The aim of this study was to assess the incidence of chlamydial respiratory tract infections in children and adolescents in the Lower Silesia Region of Poland in the year 2009.

Materials and methods

The study was performed in accordance with the Declaration of Helsinki for Human Research and the study protocol was accepted by institutional Ethics Committee. In 2009, children treated for various, non-specific respiratory illnesses in different hospital wards, in clinical departments, or as outpatients (mainly from family practices) in the Lower Silesia region were investigated for C. pneumoniae infections. The study materials were 641 throat swabs obtained from 326 girls and 315 boys, aged 11 months to 18 years. Past medical history of these patients was indicative of recurrent respiratory tract infections, long-lasting paroxysmal dry cough, rhinitis, and hoarseness. Clinical diagnoses were: bronchitis, pneumonia, sinusitis, and laryngitis. Throat swabs from the posterior wall of the pharynx were made before the start of any treatment, with the use of thin, sterile disposable swabs. Tests for the presence of C. pneumoniae antigens in throat swabs were performed by an indirect immunofluorescence antibody (IFA) technique, using the Chlamydia Cel PN testing kits (Cellabs Pty Ltd., Sydney, Australia).

Results and Discussion

The results are presented in two tables. Table 1 presents the results of throat swabs examination for C. pneumoniae in 641 children. The positive IFA test results were shown in 276 patients (43.1% of the study group), including 41.4% of girls and 44.8% of boys. The proportion of positive results was strikingly large, and it should be taken into consideration regarding epidemiologic assessment, differential diagnosis, and therapeutic management.
Table 1

Results of IFA studies for C. pneumoniae in throat swabs in children.

TotalBoysGirls
Number of cases641315326
Positive results276141135
%43.144.841.4
Results of IFA studies for C. pneumoniae in throat swabs in children. The presence of C. pneumoniae antigens in children depending on the diagnosis and the clinical symptoms is shown in Table 2. In the group of children with features of infection which manifested itself in the form of dry cough, the proportion of positive results for C. pneumoniae was 41.4%, and in the children with cough, rhinitis, and discharge from the throat - 47.2%. An assumption can be made that these are the dominant clinical symptoms of infection, since other symptoms like hoarseness occurred only in 22.9% of the examined subjects. In the group of children with symptoms of infection and having contact with sick people around them, the proportion of positive findings for C. pneumoniae was 48.3%, whereas in the children without infection in their environment this proportion was as low as 29.3%. That shows that there was a high probability of transmitting infection with cough or as droplet infection. In the group of children followed up for 14 days after the end of treatment, the presence of C. pneumoniae antigens was revealed in 54.2%. The latter observation is of a substantial interest to us, since it could have a bearing on further patients' management. The significance of this observation is, however, hampered by a relatively small number of patients, 48 (17.3%) out of the group of 276 with positive tests for the presence of C. pneumoniae antigens, who were followed up.
Table 2

Presence of C. pneumoniae antigen in children depending on diagnosis and clinical symptoms.

SymptomsDry coughCough, rhinitis, dischargeOther symptomsPatients from environment with features of infectionPatients from environment without features of infectionFollow-up after the previous treatment
Number of cases29517635602748
Positive results12283829826
%41.447.222.948.329.654.2
Presence of C. pneumoniae antigen in children depending on diagnosis and clinical symptoms.

Conclusions

The following conclusions can be drawn from the findings of this study: • In the group of children and adolescents from the Lower Silesia Region a large number of C. pneumoniae airborne and droplet infections were revealed; • The most common clinical symptoms were dry cough lasting for more than 3 weeks and rhinitis; • The diagnosis of the respiratory tract infection in a child caused by Chlamydia should be the signal for a thorough examination of people from its closest circle; Patients treated with antibiotics should always be followed up, because in nearly 50% of them the presence of Chlamydia pneumoniae can still be detected.

Conflicts of interest

The authors declare that they have no competing interests.
  9 in total

Review 1.  Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment.

Authors:  Margaret R Hammerschlag
Journal:  Pediatr Pulmonol       Date:  2003-11

2.  Detection of Chlamydophila pneumoniae IgG in paired serum samples: comparison of serological techniques in pneumonia cases.

Authors:  Fernando De Ory; María Eulalia Guisasola; José María Eiros
Journal:  APMIS       Date:  2006-04       Impact factor: 3.205

3.  [Epidemic occurrence of respiratory tract infections due to chlamydia].

Authors:  A Stawarski; I Choroszy-Król; B Iwańczak
Journal:  Pol Tyg Lek       Date:  1993 Feb 15-22

4.  Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.

Authors:  M Ben-Yaakov; G Eshel; L Zaksonski; Z Lazarovich; I Boldur
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

5.  [Chlamydia pneumoniae occurrence in children with adenoid vegetations].

Authors:  Maria Zalesska-Krecicka; Irena Choroszy-Król; Aleksandra Skrzypek; Monika Morawska-Kochman; Dorota Teryks-Wołyniec; Magdalena Frej-Madrzak; Iwona Kaufeld-Budrewicz
Journal:  Otolaryngol Pol       Date:  2006

6.  [Respiratory infection caused by Chlamydia pneumoniae].

Authors:  Paula Correia; Maria João Brito; Conceição Neves; G Cordeiro Ferreira; M do Céu Machado
Journal:  Acta Med Port       Date:  2005-10-16

7.  The influence of Chlamydia trachomatis infection on spontaneous abortions.

Authors:  M Wilkowska-Trojniel; B Zdrodowska-Stefanow; I Ostaszewska-Puchalska; S Redźko; J Przepieść; M Zdrodowski
Journal:  Adv Med Sci       Date:  2009       Impact factor: 3.287

8.  Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections.

Authors:  W C Webley; Y Tilahun; K Lay; K Patel; E S Stuart; C Andrzejewski; P S Salva
Journal:  Eur Respir J       Date:  2008-11-14       Impact factor: 16.671

9.  Chlamydia pneumoniae infection in children with lower respiratory tract infections.

Authors:  S Yamada
Journal:  Kurume Med J       Date:  1995
  9 in total
  2 in total

1.  Detection of Chlamydophila Pneumoniae and Typical Bacteria in Patients with Chronic Cough.

Authors:  A Jama-Kmiecik; M Frej-Madrzak; G Gosciniak; J Sarowska; I Choroszy-Krol
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 2.  Selected β2-, β3- and β2,3-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.

Authors:  Urszula Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.